ASOP Global Names Former U.S. Official Susan Wilson to Its Board of Directors
May 25, 2023
ASOP Global has named Susan Wilson to its Board of Directors. For more than 30 years, Susan served in technical and leadership positions at the Department of Commerce’s U.S. Patent & Trademark Office and International Trade Administration, the Office of the United States Trade Representative (USTR), the Departments of State and Justice, and the U.S. Customs Service. She is currently a director of intellectual property policy at Intel Corporation.
ASOP Global Applauds House Passage of the INFORM Consumers Act
November 17, 2022
ASOP commends the U.S. House of Representatives for passing H.R. 5502, the Integrity, Notification, and Fairness in Online Retail Marketplaces (INFORM) for Consumers Act. The bipartisan bill requires online marketplaces to verify high-volume sellers and provide consumers with their contact information. The legislation also enables law enforcement to prosecute criminals and remove counterfeit, dangerous, or defective products from online marketplaces.
Moderna Joins ASOP Global as Newest Member
June 23, 2022
The Alliance for Safe Online Pharmacies (ASOP Global) welcomed pioneering global pharmaceutical company Moderna as a new member organization today, expanding the company’s long-standing leadership on patient safety issues.
ASOP Congratulates Patient Safety Advocates and ASOP Board of Directors Members on New Leadership Roles
June 9, 2022
The Alliance for Safe Online Pharmacies (ASOP) is thrilled to congratulate President of the Board of Directors, John Hertig, PharmD, MS, FASHP, and Board Member Ilisa Bernstein on their recent promotions. Hertig has been named Chair of Pharmacy Practice in Butler University’s College of Pharmacy and Health Sciences (COPHS). Bernstein, PharmD, JD, FAPhA, has been named Interim CEO of the American Pharmacists Association (APhA).
ASOP Global Urges Swift Passage of the INFORM Consumers Act
October 14, 2021
ASOP Global applauds Congress for moving the INFORM Consumers Act quickly through the legislative process and urges the bill’s swift passage to send a powerful message to online criminals that they can no longer act anonymously and without punishment.
ASOP Global Condemns Websites Falsely Marketing Ivermectin as a COVID Cure
September 15, 2021
ASOP Global joins members of the American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP), along with the American Medical Association (AMA), in warning against the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
ASOP Global Opposes New Biden Policy on Canadian Drug Importation.
July 12, 2021
Friday, President Biden issued an Executive Order that directs the Food and Drug Administration (FDA) to work with states and tribes on plans to import prescription drugs from Canada. In response, Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Expresses Support for SHOP SAFE Act
May 26, 2021
The Alliance for Safe Online Pharmacies issued the following statement in support of the “Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce Act” (SHOP SAFE Act) and this week’s congressional hearing on the legislation.
ASOP Global Endorses INFORM Consumers Act
May 25, 2021
the Alliance for Safe Online Pharmacies issued the following statement in support of the bipartisan Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act (INFORM Consumers Act).
ASOP Global Applauds NTIA for Urging Congress to Protect Americans Online
January 6, 2021
As a member of the Coalition for a Secure and Transparent Internet (CSTI), the Alliance for Safe Online Pharmacies (ASOP Global) signed recent letters applauding the National Telecommunications and Information Administration (NTIA) for calling on the House and Senate to address open access to accurate WHOIS data.
ASOP Global Commends U.S. Attorney Hur for Fighting Against COVID-19 Fraud
December 21, 2020
In response to the recent seizure by the U.S. Attorney’s Office for the District of Maryland of websites for fraudulently posing as legitimate biotechnology companies actively developing treatments for COVID-19, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Urges Consumers to Remain Aware of COVID-19 Fraud
December 11, 2020
In response to the anticipated emergency use authorizations (EUAs) for several COVID-19 vaccines and availability of a direct-to-consumer COVID-19 test system, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Statement of Opposition to Drug Importation Rule
November 30, 2020
In response to the U.S. Food and Drug Administration’s (FDA) Importation of Prescription Drugs Final Rule taking effect today, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement of opposition.
ASOP Global Statement on New Section 230 Reform Bill
September 29, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the introduction today of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).
In response to the newly released report by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) entitled “Illicit Trade in Counterfeit Pharmaceutical Products,” the Alliance for Safe Online Pharmacy in the EU (ASOP EU) applauds the research conducted to better highlight and quantify the pervasive threat of illegal online drug sellers.
